Incidental Mutation 'R9012:Lzts1'
ID 685697
Institutional Source Beutler Lab
Gene Symbol Lzts1
Ensembl Gene ENSMUSG00000036306
Gene Name leucine zipper, putative tumor suppressor 1
Synonyms FEZ1, PSD-Zip70, F37
MMRRC Submission 068842-MU
Accession Numbers
Essential gene? Non essential (E-score: 0.000) question?
Stock # R9012 (G1)
Quality Score 225.009
Status Validated
Chromosome 8
Chromosomal Location 69585321-69636877 bp(-) (GRCm39)
Type of Mutation missense
DNA Base Change (assembly) C to T at 69593550 bp (GRCm39)
Zygosity Heterozygous
Amino Acid Change Arginine to Histidine at position 19 (R19H)
Ref Sequence ENSEMBL: ENSMUSP00000039397 (fasta)
Gene Model predicted gene model for transcript(s): [ENSMUST00000037049] [ENSMUST00000185176]
AlphaFold P60853
Predicted Effect probably damaging
Transcript: ENSMUST00000037049
AA Change: R19H

PolyPhen 2 Score 0.999 (Sensitivity: 0.14; Specificity: 0.99)
SMART Domains Protein: ENSMUSP00000039397
Gene: ENSMUSG00000036306
AA Change: R19H

DomainStartEndE-ValueType
low complexity region 50 62 N/A INTRINSIC
low complexity region 305 350 N/A INTRINSIC
Pfam:Fez1 378 568 3.9e-68 PFAM
Predicted Effect probably damaging
Transcript: ENSMUST00000185176
AA Change: R19H

PolyPhen 2 Score 0.999 (Sensitivity: 0.14; Specificity: 0.99)
SMART Domains Protein: ENSMUSP00000139117
Gene: ENSMUSG00000036306
AA Change: R19H

DomainStartEndE-ValueType
low complexity region 50 62 N/A INTRINSIC
low complexity region 305 350 N/A INTRINSIC
Pfam:Fez1 378 569 2.3e-79 PFAM
Coding Region Coverage
  • 1x: 100.0%
  • 3x: 99.9%
  • 10x: 99.6%
  • 20x: 98.7%
Validation Efficiency 100% (61/61)
MGI Phenotype FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] This gene encodes a tumor suppressor protein that is ubiquitously expressed in normal tissues. In uveal melanomas, expression of this protein is silenced in rapidly metastasizing and metastatic tumor cells but has normal expression in slowly metastasizing or nonmetastasizing tumor cells. This protein may have a role in cell-cycle control by interacting with the Cdk1/cyclinB1 complex. This gene is located on chromosomal region 8p22. Loss of heterozygosity (LOH) in the 8p arm is a common characteristic of many types of cancer. [provided by RefSeq, Nov 2009]
PHENOTYPE: Heterozygous or homozygous inactivation of this gene leads to increased incidence of spontaneous and carcinogen-induced tumors. Homozygtes for a null allele show working memory and cognitive deficits, enhanced anxiety, defects in glutamatergic synaptic transmission, and impaired spine maturation. [provided by MGI curators]
Allele List at MGI
Other mutations in this stock
Total: 61 list
GeneRefVarChr/LocMutationPredicted EffectZygosity
Agt T C 8: 125,290,954 (GRCm39) N118D probably benign Het
Apol8 T C 15: 77,634,324 (GRCm39) D84G probably benign Het
Arl6ip5 T A 6: 97,187,838 (GRCm39) D19E probably benign Het
B3gnt3 G T 8: 72,145,673 (GRCm39) H232N probably damaging Het
Btbd10 T C 7: 112,921,964 (GRCm39) K347R probably damaging Het
Capn5 C T 7: 97,814,050 (GRCm39) probably benign Het
Ccdc181 C T 1: 164,110,062 (GRCm39) R390W probably damaging Het
Cdc42bpa T C 1: 179,859,077 (GRCm39) V93A Het
Cfap91 T C 16: 38,122,335 (GRCm39) E712G probably damaging Het
Clcn1 A G 6: 42,268,567 (GRCm39) I191V possibly damaging Het
Coro1c T C 5: 113,988,737 (GRCm39) D202G probably damaging Het
Cul9 A G 17: 46,854,447 (GRCm39) I85T probably benign Het
Cyp2c55 C T 19: 39,030,560 (GRCm39) T464I probably benign Het
Dlgap1 G A 17: 70,823,182 (GRCm39) E56K possibly damaging Het
Dnajc6 T C 4: 101,470,156 (GRCm39) F298L probably damaging Het
E130311K13Rik A T 3: 63,822,934 (GRCm39) W237R probably damaging Het
Efcab3 G A 11: 104,711,347 (GRCm39) probably null Het
Fes T A 7: 80,032,884 (GRCm39) D287V possibly damaging Het
Fstl5 G T 3: 76,567,027 (GRCm39) W557L probably damaging Het
Gad2 A G 2: 22,580,263 (GRCm39) N555D possibly damaging Het
Gm10277 C T 11: 77,676,848 (GRCm39) R41K unknown Het
Gm21834 T C 17: 58,049,162 (GRCm39) E18G probably null Het
Hnrnpul2 T C 19: 8,801,829 (GRCm39) F346L possibly damaging Het
Hspa4 A T 11: 53,159,402 (GRCm39) V524E probably benign Het
Ikbke T C 1: 131,201,190 (GRCm39) I207V probably damaging Het
Iqsec3 T C 6: 121,389,996 (GRCm39) I492V unknown Het
Itsn1 C A 16: 91,645,849 (GRCm39) F846L unknown Het
Ldhal6b A T 17: 5,467,942 (GRCm39) Y331N probably damaging Het
Lrrc37a T G 11: 103,389,978 (GRCm39) T1816P probably benign Het
Mast4 T A 13: 102,934,606 (GRCm39) T338S probably benign Het
Mst1r A G 9: 107,791,960 (GRCm39) E832G probably benign Het
Myom1 T G 17: 71,407,103 (GRCm39) D1173E probably benign Het
Nlrp9c T A 7: 26,074,733 (GRCm39) I821F probably benign Het
Obscn T C 11: 59,021,423 (GRCm39) K806E probably benign Het
Or2ag13 T C 7: 106,313,115 (GRCm39) M258V probably benign Het
Or4c120 A G 2: 89,000,929 (GRCm39) I209T possibly damaging Het
Or6c215 A C 10: 129,637,471 (GRCm39) S308A probably benign Het
Palld T A 8: 62,173,697 (GRCm39) S321C possibly damaging Het
Pank4 C A 4: 155,062,847 (GRCm39) probably benign Het
Prr35 A G 17: 26,166,685 (GRCm39) L284P probably benign Het
Psg26 T A 7: 18,216,596 (GRCm39) H81L probably benign Het
Ptprq C T 10: 107,489,411 (GRCm39) E905K probably benign Het
Siglecg T A 7: 43,060,523 (GRCm39) L301Q probably damaging Het
Slc25a15 A G 8: 22,867,878 (GRCm39) W301R probably benign Het
Slco1b2 T A 6: 141,602,554 (GRCm39) V169D probably damaging Het
Sned1 T C 1: 93,212,320 (GRCm39) V1174A probably damaging Het
Sorl1 A G 9: 41,982,491 (GRCm39) V363A probably damaging Het
Sppl3 C A 5: 115,226,987 (GRCm39) P239T probably benign Het
Stox1 A T 10: 62,500,611 (GRCm39) S650T probably benign Het
Tbc1d9b A G 11: 50,040,688 (GRCm39) T402A probably benign Het
Tmem104 A T 11: 115,092,144 (GRCm39) E84D probably benign Het
Tox4 T C 14: 52,523,208 (GRCm39) V56A probably benign Het
Trav7-6 A G 14: 53,954,604 (GRCm39) K65E probably benign Het
Treml2 A G 17: 48,615,090 (GRCm39) T192A possibly damaging Het
Vmn2r110 T C 17: 20,803,627 (GRCm39) D316G probably damaging Het
Vmn2r5 A T 3: 64,411,915 (GRCm39) W218R probably damaging Het
Vwa3b A G 1: 37,124,391 (GRCm39) S330G probably benign Het
Wdr81 A G 11: 75,339,971 (GRCm39) V220A possibly damaging Het
Zbbx A G 3: 74,968,960 (GRCm39) S504P possibly damaging Het
Zfp68 A T 5: 138,605,283 (GRCm39) C347S probably damaging Het
Zfp936 T A 7: 42,839,416 (GRCm39) C294* probably null Het
Other mutations in Lzts1
AlleleSourceChrCoordTypePredicted EffectPPH Score
IGL01065:Lzts1 APN 8 69,588,744 (GRCm39) missense probably benign 0.07
IGL01313:Lzts1 APN 8 69,591,759 (GRCm39) missense probably benign 0.11
IGL02371:Lzts1 APN 8 69,591,450 (GRCm39) missense probably damaging 0.99
IGL02508:Lzts1 APN 8 69,593,500 (GRCm39) nonsense probably null
IGL03238:Lzts1 APN 8 69,591,446 (GRCm39) missense probably damaging 1.00
R0645:Lzts1 UTSW 8 69,588,392 (GRCm39) missense possibly damaging 0.92
R1442:Lzts1 UTSW 8 69,591,638 (GRCm39) missense probably damaging 0.99
R1887:Lzts1 UTSW 8 69,591,485 (GRCm39) missense probably damaging 1.00
R2366:Lzts1 UTSW 8 69,593,257 (GRCm39) splice site probably null
R4238:Lzts1 UTSW 8 69,588,579 (GRCm39) missense possibly damaging 0.61
R4489:Lzts1 UTSW 8 69,588,347 (GRCm39) missense possibly damaging 0.94
R4508:Lzts1 UTSW 8 69,588,270 (GRCm39) missense probably benign 0.00
R4965:Lzts1 UTSW 8 69,591,414 (GRCm39) missense probably benign 0.44
R5159:Lzts1 UTSW 8 69,591,236 (GRCm39) missense probably benign 0.44
R5643:Lzts1 UTSW 8 69,591,729 (GRCm39) missense possibly damaging 0.94
R5644:Lzts1 UTSW 8 69,591,729 (GRCm39) missense possibly damaging 0.94
R5782:Lzts1 UTSW 8 69,593,350 (GRCm39) missense probably benign 0.00
R6146:Lzts1 UTSW 8 69,593,524 (GRCm39) missense probably benign 0.01
R7069:Lzts1 UTSW 8 69,593,397 (GRCm39) missense probably damaging 1.00
R7444:Lzts1 UTSW 8 69,588,331 (GRCm39) missense probably damaging 1.00
R8088:Lzts1 UTSW 8 69,588,474 (GRCm39) missense probably benign 0.01
R8100:Lzts1 UTSW 8 69,593,397 (GRCm39) missense probably damaging 1.00
R9545:Lzts1 UTSW 8 69,591,286 (GRCm39) missense probably damaging 1.00
Predicted Primers PCR Primer
(F):5'- TCAAAATCTACTCCGGTCTGACC -3'
(R):5'- CCCAGGCTCTAAGAAGCTTTTG -3'

Sequencing Primer
(F):5'- CACTGGACAGGGCTGTGTAGTC -3'
(R):5'- GCTCTGACCACAGTCCCCTG -3'
Posted On 2021-10-11